Images List Premium Download Classic

Bowel

Bowel-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Methods of detecting inflammatory markers and treating inflammatory conditions in humans
Vetica Labs, Inc.
February 15, 2018 - N°20180045724

The present invention provides methods and systems to accurately detect and measure in a biological sample from a patient, endogenous antibodies, e. G., iga, to inflammatory proteins, which antibodies are useful as diagnostic markers for inflammatory conditions, including bowel disease (ibd), in patients. Such methods and systems identify whether a sample from the patient is associated with an inflammatory condition, ...
Antigens associated with inflammatory bowel disease
Philogen S.p.a.
February 15, 2018 - N°20180044408

Specific binding members that bind the ed-a isoform of fibronectin for use in methods of treatment, diagnosis, detection and/or imaging of inflammatory bowel disease (ibd), and/or for use in delivery to the ibd tissue of a molecule conjugated to the specific binding member. The specific binding member may, for example, be conjugated to an immunosupressive or anti-inflammatory molecule, ...
Compositions and methods for treating retinal degradation
University Of Kentucky Research Foundation
February 15, 2018 - N°20180044327

The present disclosure relates to compounds, compositions, and methods useful for treating retinal damage and/or retinal degradation/retinal degeneration, for inhibiting inflammasome activation by alu rna associated with a cell, for reducing atp-induced permeability of a cell, for reducing an amount of mitochondrial reactive oxygen species in a cell, and for reducing an amount of mitochondrial reactive oxygen species ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Hydrocortisone acetate suppository formulation for treatment of disease
Criscot Llc
February 08, 2018 - N°20180036235

The present invention relates, in various embodiments, to formulations comprising hydrocortisone and silicon dioxide. In additional embodiments, the invention relates to suppositories comprising hydrocortisone and silicon dioxide. The formulations of the present invention are useful for administration to patients who have gastrointestinal diseases and disorders such as, for example, inflammatory bowel disease.
Antisense oligonucleotides (odn) against smad7 and uses thereof in medical field
Nogra Pharma Limited
February 01, 2018 - N°20180030450

The invention relates to antisense oligonucleotidic sequences (odn) against smad7 suitably modified, and their uses in medical field as therapeutic biological agents, in particular in the treatment of chronic inflammatory bowel disease, such as crohn's disease and ulcerative colitis.
Compositions and methods of using a soluble tnf-alpha receptor modified for increased half-life
Dnx Biotech, Llc
February 01, 2018 - N°20180028612

Methods and pharmaceutical compositions for preventing and/or treating acute and chronic inflammation and autoimmune diseases are provided herein. Tumor necrosis factor-α (tnfα) promotes an inflammatory response, which causes clinical problems associated with inflammation and autoimmune disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, psoriasis, hidradenitis suppurativa, and refractory asthma. Tnfα is ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Use of collinsella for treatment of inflammatory bowel disease
Swecure Ab
February 01, 2018 - N°20180028579

A composition comprising a carrier and a therapeutically effective amount of at least one micro-organism, the micro-organism being collinsella, is useful in the prevention or treatment of inflammatory bowel disease in mammals.
Use of albiflorin or pharmaceutically acceptable salt for prevention and/or treatment of irritable bowel ...
February 01, 2018 - N°20180028550

Disclosed is a use of albiflorin or a pharmaceutically acceptable salt for the prevention and/or treatment of irritable bowel syndrome. The experimental results demonstrate that the prevention, remission and/or treatment of irritable bowel syndrome with albiflorin or a pharmaceutically acceptable salt has significant effects and few side effects. This is a preparation derived from a natural plant for ...
Biomarker
Isis Innovation Limited
January 25, 2018 - N°20180022800

The invention relates to methods of treating chronic intestinal inflammation and/or inflammatory bowel disease by administering an antagonist of oncostatin-m (osm) and/or osm receptor-β (osmr). The invention also relates to methods for diagnosing or prognosing chronic intestinal inflammation and/or inflammatory bowel disease in an individual and for predicting whether or not an individual will respond ...
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
Protagonist Therapeutics, Inc.
January 25, 2018 - N°20180022778

The present invention provides novel peptide inhibitors of the interleukin-23 receptor, and related compositions and methods of using these peptide inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel disease.
Multiplexed assay kit to evaluate the efficacy of treatment for inflammatory bowel disease
Meso Scale Technologies, Llc.
January 18, 2018 - N°20180017578

Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the present invention. Also described are methods for monitoring patient's treatment by administering tests of the present invention. Also described are methods for evaluating the effectiveness ...
Method for detecting methylation of colorectal cancer specific methylation marker gene for colorectal cancer diagnosis
Genomictree, Inc.
January 18, 2018 - N°20180016644

The present disclosure relates to a method for detecting methylation of the bowel-cancer-specific methylation marker gpm6a (nm_201591, glycoprotein m6a) gene in order to diagnose bowel cancer, and more specifically relates to a method for providing information for diagnosing bowel cancer by detecting the methylation of a bowel-cancer-specific marker gene that is specifically methylated in bowel cancer cells. The ...
Novel dihydropyrimidinoisoquinolinones and pharmaceutical compositions thereof for the treatment of inflammatory disorders (gpr84 antagonists)
January 18, 2018 - N°20180016275

The present invention relates to novel compounds according to formula i that antagonize gpr84, a g-protein-coupled receptor that is involved in inflammatory conditions, and methods for the production of these novel compounds, pharmaceutical compositions comprising these compounds, and methods for the prevention and/or treatment of inflammatory conditions (for example inflammatory bowel diseases (ibd), rheumatoid arthritis, vasculitis), lung diseases (e. ...
Bowel Patent Pack
Download 226+ patent application PDFs
Bowel Patent Applications
Download 226+ Bowel-related PDFs
For professional research & prior art discovery
inventor
  • 226+ full patent PDF documents of Bowel-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Stabilized liquid formulations containing picosulfate
Ferring B.v.
January 18, 2018 - N°20180015078

Stable liquid formulations containing picosulfate and magnesium citrate are provided. The formulations are useful to treat constipation or for the clearance of the bowel prior to x-ray examination, endoscopy or surgery.
Compositions and methods for managing digestive disorders and a healthy microbiome
Metagenics, Inc.
January 18, 2018 - N°20180015032

Disclosed is a prebiotic composition comprising a combination of 2′fucosyllactose (2′fl) and isomaltooligosaccharide (imo). The 2′fl and imo are present in the prebiotic composition in a weight ratio of from 1:1 to 1:10. The prebiotic composition is effective for use in methods of preventing and/or treating a gastrointestinal (gi) condition in an animal, such as irritable bowel syndrome (...
Biomarkers for inflammatory bowel disease
Cambridge Enterprise Limited
January 11, 2018 - N°20180010189

The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (ibd) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating ibd in an individual who is determined to be at high risk or low risk ...
Biomarkers for inflammatory bowel disease
Cambridge Enterprise Limited
January 11, 2018 - N°20180010187

The present invention provides a method of assessing whether an individual is at high risk or low risk of inflammatory bowel disease (ibd) progression by determining the expression level of two or more genes in a whole blood sample. Also provided are methods for treating ibd in an individual who is determined to be at high risk or low risk ...
Dosage form containing oxycodone and naloxone
Purdue Pharma L.p.
January 11, 2018 - N°20180008593

The present invention concerns a dosage form comprising oxycodone and naloxone which is characterized by specific in vivo parameters such as tmax, cmax, auct value, mean bowel function score and/or duration of analgesic efficacy.
Organ retractor
January 11, 2018 - N°20180008254

A medical device of the present invention includes one or more anchors and an elongated member. Advantageously, the elongated member may be coupled to the anchors. The elongated member and anchors are configured to generate a force on a mesentery. The force is sufficient to retract a bowel of the patient into an upper portion of an abdominal cavity of ...
Bacillus coagulans mtcc 5856 for the management of major depressive disorder
January 04, 2018 - N°20180000873

The present invention discloses the use of probiotics for therapeutic management of major depressive disorder (mdd). Specifically, the invention discloses the method of therapeutically managing mdd in mammals with irritable bowel syndrome using probiotic strain bacillus coagulans mtcc 5856.
Treatment of th17 mediated inflammatory diseases
Genentech, Inc.
December 28, 2017 - N°20170369885

The present invention provides methods and means to reduce inflammation associated with irf-4, ap-1 and th17 mediated diseases. In particular, the invention provides methods and means to treat multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and psoriasis and related conditions.
Loading